Inhibition or lack of NAD(P)H oxidase subunits do not alter the normal cytosolic calcium, sensory and respiratory response of chemoreceptors.
Rozanov
C
C
University of Pennsylvania School of Medicine, Philadephia, USA.
Roy
A
A
Mokashi
A
A
Daudu
P
P
Ross
C
C
Lahiri
S
S
D000818:Animals; D023181:Antimicrobial Cationic Peptides / Q000494:pharmacology; D001713:Biphenyl Compounds / Q000494:pharmacology; D002118:Calcium / Q000378:metabolism; D002346:Carotid Sinus / Q000294:innervation; D002628:Chemoreceptor Cells / Q000378:metabolism; D003600:Cytosol / Q000378:metabolism; D004594:Electrophysiology; D004791:Enzyme Inhibitors / Q000494:pharmacology; D008562:Membrane Glycoproteins / Q000235:genetics / Q000502:physiology; D051379:Mice; D018345:Mice, Knockout; D009247:NADH, NADPH Oxidoreductases / Q000037:antagonists & inhibitors / Q000378:metabolism*; D000074662:NADPH Oxidase 2; D019255:NADPH Oxidases; D009474:Neurons / Q000187:drug effects / Q000502:physiology; D009861:Onium Compounds / Q000494:pharmacology; D010750:Phosphoproteins / Q000235:genetics / Q000502:physiology; D012123:Pulmonary Ventilation / Q000187:drug effects / Q000502:physiology*; D051381:Rats
D023181:Antimicrobial Cationic Peptides; D001713:Biphenyl Compounds; D004791:Enzyme Inhibitors; D008562:Membrane Glycoproteins; D009861:Onium Compounds; D010750:Phosphoproteins; C031291:diphenyliodonium; C072212:PR 39; D009247:NADH, NADPH Oxidoreductases; C056558:CYBB protein, human; D000074662:NADPH Oxidase 2; D019255:NADPH Oxidases; C060505:neutrophil cytosolic factor 1; D002118:Calcium